Article
Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique.
Pharmacogenomics - 1 Jan 2010
Ciccacci Cinzia, Borgiani Paola, Ceffa Susanna, Sirianni Elisabetta, Marazzi Maria C, Altan Anna M Doro, Paturzo Giovanna, Bramanti Placido, Novelli Giuseppe, Palombi Leonardo
Abstract excerpt
AIMS: Nevirapine is widely used to treat HIV-1 infection to prevent mother-to-child transmission; unfortunately adverse drug reactions have been reported. Our aim was to identify genes/variants involved in nevirapine-induced hepatotoxicity. MATERIALS & METHODS: Patients from Mozambique, 78 with nevirapine-induced hepatotoxicity and 78 without adverse events, were genotyped for ABCB1, CYP2B6, CYP3A4 and CYP3A5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
